pf-8046052
Generic: EGFRd2·Code: PF-8046052, LAVA-1223, SGN-EGFRd2
pf-8046052: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| LAVA Therapeutics NV (LVTX) | Phase 1 |
Get deeper analysis on pf-8046052
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis